LDL-cholesterol lowering: to be or not to be too low

被引：2

作者：

Duprez, Daniel ^{[1
]}

Jacobs Jr, David R. ^{[2
]}

机构：

[1] Univ Minnesota, Dept Med, Cardiovasc Div, 420 Delaware St SE,MMC 508, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 420 Delaware St SE,MMC 508, Minneapolis, MN 55455 USA

来源：

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2023年 / 30卷 / 12期

关键词：

HEMORRHAGIC STROKE; RISK; THERAPY; STATINS;

D O I：

10.1093/eurjpc/zwad143

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1205 / 1206

页数：2

共 14 条

[1] Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies [J].

Adhikari, Anish ;

Tripathy, Swetapadma ;

Chuzi, Sarah ;

Peterson, Jonna ;

Stone, Neil J. .

JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (01) :22-+

[2] Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis [J].

Alvarez-Jimenez, Laura ;

Morales-Palomo, Felix ;

Moreno-Cabanas, Alfonso ;

Ortega, Juan F. ;

Mora-Rodriguez, Ricardo .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 947

[3] Intracranial Hemorrhage in the TST Trial [J].

Amarenco, Pierre ;

Kim, Jong S. ;

Labreuche, Julien ;

Charles, Hugo ;

Giroud, Maurice ;

Lavallee, Philippa C. ;

Lee, Byung-Chul ;

Mahagne, Marie-Helene ;

Meseguer, Elena ;

Nighoghossian, Norbert ;

Steg, Philippe Gabriel ;

Vicaut, Eric ;

Bruckert, Eric .

STROKE, 2022, 53 (02) :457-462

[4]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

[5] Statins and Higher Diabetes Mellitus Risk: Incidence, Proposed Mechanisms, and Clinical Implications [J].

Guber, Kenneth ;

Pemmasani, Gayatri ;

Malik, Aaqib ;

Aronow, Wilbert S. ;

Yandrapalli, Srikanth ;

Frishman, William H. .

CARDIOLOGY IN REVIEW, 2021, 29 (06) :314-322

[6] Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials [J].

Guedeney, Paul ;

Giustino, Gennaro ;

Sorrentino, Sabato ;

Claessen, Bimmer E. ;

Camaj, Anton ;

Kalkman, Deborah N. ;

Vogel, Birgit ;

Sartori, Samantha ;

De Rosa, Salvatore ;

Baber, Usman ;

Indolfi, Ciro ;

Montalescot, Gilles ;

Dangas, George D. ;

Rosenson, Robert S. ;

Pocock, Stuart J. ;

Mehran, Roxana .

EUROPEAN HEART JOURNAL, 2022, 43 (07) :E17-E25

[7] Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study [J].

Janik, Matthew J. ;

Urbach, Dorothea, V ;

van Nieuwenhuizen, Elane ;

Zhao, Jian ;

Yellin, Ori ;

Baccara-Dinet, Marie T. ;

Pordy, Robert ;

Manvelian, Garen .

ATHEROSCLEROSIS, 2021, 331 :20-27

[8] Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analyses [J].

Liu, Hongwei ;

Li, Jianxin ;

Liu, Fangchao ;

Huang, Keyong ;

Cao, Jie ;

Chen, Shufeng ;

Li, Hongfan ;

Shen, Chong ;

Hu, Dongsheng ;

Huang, Jianfeng ;

Lu, Xiangfeng ;

Gu, Dongfeng .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (12) :1207-1215

[9] Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association [J].

Newman, Connie B. ;

Preiss, David ;

Tobert, Jonathan A. ;

Jacobson, Terry A. ;

Page, Robert L., II ;

Goldstein, Larry B. ;

Chin, Clifford ;

Tannock, Lisa R. ;

Miller, Michael ;

Raghuveer, Geetha ;

Duell, P. Barton ;

Brinton, Eliot A. ;

Pollak, Amy ;

Braun, Lynne T. ;

Welty, Francine K. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (02) :E38-E81

[10] PCSK9 inhibitors: clinical evidence and implementation [J].

Sabatine, Marc S. .

NATURE REVIEWS CARDIOLOGY, 2019, 16 (03) :155-165

← 1 2 →